Mortality after long-term exposure to radioactive Thorotrast: A forty- year follow-up survey in Sweden

Radiation Research

Volumn 151, Issue 3, 1999, Pages 293-299

  Martling, Ullakarin ^a   Mattsson, Anders ^a   Travis, Lois B ^b   Holm, Lars Erik ^c   Hall, Per ^a,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Swedish Radiation Protection Authority   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; THORIUM DIOXIDE;

ADOLESCENT; ADULT; AGED; ALPHA RADIATION; ARTICLE; BRAIN ANGIOGRAPHY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHILD; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK ASSESSMENT; SWEDEN; TUMOR;

STAPHYLOCOCCUS PHAGE 187;

EID: 0032976613     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579941     Document Type: Article

References (48)

1. D. L. Preston, S. Kusumi, M. Tomonaga, S. Izumi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy, T. Matsuo and K. Mabuchi, Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat. Res. 137 (Suppl.), S68-S97 (1994).
2. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki and D. L. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (Suppl.), S17-S67 (1994).
3. A. F. Stehney, Survival times of pre-1950 U.S. women radium dial workers. In Health Effects of Internally Deposited Radionuclides: Emphasis on Radium and Thorium (G. van Kaick, A. Karaoglou and A. M. Kellerer, Eds.), pp. 149-155. World Scientific, Singapore, 1995.
4. J. H. Lubin and J. D. Boice, Jr., Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J. Natl. Cancer Inst. 89, 49-57 (1997).
5. J. D. Boice, Jr., N. E. Day, A. Andersen, L. A. Brinton, R. Brown, N. W. Choi, E. A. Clarke, M. P. Coleman, R. E. Curtis and C. Wall, Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J. Natl. Cancer Inst. 74, 955-975 (1985).
6. S. C. Darby, R. Doll, S. K. Gill and P. G. Smith, Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br. J. Cancer 55, 179-190 (1987).
7. H. A. Weiss, S. C. Darby and R. Doll, Cancer mortality following X-ray treatment for ankylosing spondylitis. Int. J. Cancer 59, 327-338 (1994).
8. J. M. Jones and G. G. Riberio, Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin. Radiol. 40, 204-208 (1989).
9. S. H. Levitt, Cardiac damage following radiation treatment of primary breast cancer: assessing the risk, exploring the cause. Int. J. Radiat. Oncol. Biol. Phys. 22, 1157-1158 (1992).
10. Y. Shimizu, H. Kato, W. J. Schull and D. G. Hoel, Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat. Res. 130, 249-266 (1992).
11. F. L. Wong, M. Yamada, H. Sasaki, K. Kodama, S. Akiba, K. Shimaoaka and Y. Hosoda, Noncancer disease incidence in the atomic bomb survivors: 1958-1986. Radiat. Res. 135, 418-430 (1993).
12. G. Gyenes, T. Fornander, P. Carlens, U. Glas and L. E. Rutqvist, Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study. Int. J. Radiat. Oncol. Biol. Phys. 36, 899-905 (1996).
13. J. D. Abbatt, History of the use and toxicity of Thorotrast. Environ. Res. 18, 6-12 (1979).
14. M. L. Janover, O. S. Miettinen and M. J. Flynn, Effects of long-term Thorotrast exposure. Radiology 103, 13-20 (1972).
15. J. da Silva Horta, M. E. da Silva Horta, L. Cayolla da Motta and M. H. Tavares, Malignancies in Portuguese Thorotrast patients. Health Phys. 35, 137-151 (1978).
16. T. Mori and Y. Kato, Epidemiological, pathological and dosimetric status of Japanese Thorotrast patients. J. Radiat. Res. 32 (Suppl. 2), 34-45 (1991).
17. M. Andersson, B. Carstensen and H. H. Storm, Mortality and cancer incidence after cerebral arteriography with or without Thorotrast. Radiat. Res. 142, 305-320 (1995).
18. G. van Kaick, H. Wesch, H. Luehrs, D. Liebermann and A. Kaul, Epidemiological results and dosimetric calculations - an update of the German Thorotrast study. In Health Effects of Internally Deposited Radionuclides: Emphasis on Radium and Thorium (G. van Kaick, A. Karaoglou and A. M. Kellerer, Eds.), pp. 171-175. World Scientific, Singapore, 1995.
19. S. Dahlgren, Late effects of thorium dioxide on the liver of patients in Sweden. Ann. NY Acad. Sci. 145, 718-723 (1967).
20. R. Blomberg, L-E. Larsson, B. Lindell and E. Lindgren, Late effects of Thorotrast in cerebral angiography. Acta Radial. Diagn. 1, 995-1006 (1963).
21. Manual of the International Classification of Diseases, Injuries and Causes of Death (ICD-6), 1945 revision. World Health Organization, Geneva, 1948.
22. International Classification of Diseases, Injuries and Causes of Death (ICD-7), 1955 revision. World Health Organization, Geneva, 1957.
23. International Classification of Diseases, Injuries and Causes of Death (ICD-S), 1965 revision. World Health Organization, Geneva, 1967.
24. International Classification of Diseases, Ninth Revision (ICD-9). World Health Organization, Geneva, 1987.
25. M. P. Coleman, C. Hermon and A. Douglas, Person-years (PYRS). A FORTRAN Program for Cohort Study Analysis. IARC Internal Report No. 89/006, International Agency for Research on Cancer, Lyon, 1989.
26. D. L. Preston, J. H. Lubin, D. A. Pierce and M. E. McConney, EPICURE User's Guide. Hirosoft International Corp, Seattle, WA, 1988.
27. B. I. Lindahl and L. A. Johansson, Multiple cause-of-death data as a tool for detecting artificial trends in the underlying cause statistics: a methodological study. Scand. J. Soc. Med. 22, 145-158 (1994).
28. B. Jansson, L. A. Johansson, M. Rosén and L. Svanström, National adaptations of the ICD rules for classification - a problem in the evaluation of cause-of-death trends. J. Clin. Epidemiol. 50, 367-375 (1997).
29. M. Andersson, K. Juel and H. H. Storm, Pattern of mortality among Danish Thorotrast patients. J. Clin. Epidemiol. 46, 637-644 (1993).
30. Y. Ishikawa, Y. Kato and S. Hatakeyama, Late effects of α-particles on Thorotrast patients in Japan. In Risks from Radium and Thorotrast (D. M. Taylor, C. W. Mays, G. B. Gerber and R. G. Thomas, Eds.), pp. 129-131. BIR Report 21, British Institute of Radiology, London, 1989.
31. Y. Ishikawa, T. Mori, Y. Kato, R. Machinami, N. D. Priest and T. Kitagawa, Systemic deposits of thorium in Thorotrast patients with particular reference to sites of minor storage. Radiat. Res. 135, 244-248 (1993).
32. J. da Silva Horta, Late effects of Thorotrast on the liver and spleen, and their efferent lymph node. Ann. NY Acad. Sci. 145, 676-699 (1967).
33. T. P. C. Monath and E. C. Borden, Effects of Thorotrast on humoral antibody, viral multiplication, and interferon during infection with St. Louis encephalitis virus in mice. J. Infect. Dis. 123, 297-300 (1971).
34. M. Abe and H. Wakasa, Thorotrast-induced hepatic angiosarcoma with 39 years latency. A pathologic and immunohistochemical study. Acta Pathol. Jpn. 37, 1653-1660 (1987).
35. L. E. Rutqvist, I. Lax, T. Fornander and H. Johansson, Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 22, 887-896 (1992).
36. J. Stewart, L. Fajardo, S. M. Gillette and L. S. Constine, Radiation injury to the heart. Int. J. Radiat. Oncol. Biol. Phys. 31, 1205-1211 (1995).
37. G. Gagliardi, I. Lax, A. Ottolenghi and L. E. Rutqvist, Long-term cardiac mortality after radiotherapy of breast cancer-application of the relative seriality model. Br. J. Radiol. 69, 839-846 (1996).
38. E. S. Hansen, International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/ 1/2. Shared risk factors for cancer and atherosclerosis - a review of the epidemiological evidence. Mutat. Res. 239, 163-179 (1990).
39. R. K. Mulhern, E. Kovnar, J. Langston, M. Carter, D. Fairclough, L. Leigh and L. E. Kun, Long-term survivors of leukemia treated in infancy: Factors associated with neurophsychologic status. J. Clin. Oncol. 10, 1095-1102 (1992).
40. H. Wesch, G. van Kaick, W. Riedel, A. Kaul, K. Wegener, K. Hasenöhrl, H. Immich and H. Muth, Recent results of the German Thorotrast study - statistical evaluation of animal experiments with regard to the nonradiation effects in human thorotrastosis. Health Phys. 44, (Suppl. 1), 317-321 (1983).
41. T. Mori, Y. Kato, H. Matsudaira, R. Machinami, Y. Akita, K. Fukutomi, S. Hatakeyama, H. Tanooka, T. Maruyama and T. Kumatori, Recent results in the first series of the Japanese follow-up study of Thorotrast patients and their relationships with statistical analyses of autopsy series. In Health Effects of Internally Deposited Radionuclides: Emphasis on Radium and Thorium (G. van Kaick, A. Karaoglou and A. M. Kellerer, Eds.), pp. 181-191. World Scientific, Singapore, 1995.
42. C. W. Mays, Alpha-particle-induced cancer in humans. Health Phys. 55, 637-652 (1988).
43. C. van Kaick, H. Muth, A. Kaul, H. Wesch, H. Immich, D. Liebermann, D. Lorenz, W. J. Lorenz, H. Lührs, K. E. Schecr, G. Wagner and K. Wegener, Report on the German Thorotrast Study. Strahlentherapie 80, 114-118 (1985).
44. A. Kaul and W. Noffz, Tissue dose in Thorotrast patients. Health Phys. 35, 113-121 (1978).
45. A. R. Dahleimer and A. Kaul, Calculations of local dose to tissues adjacent to Thorotrast conglomerates. In Risks from Radium and Thorotrast (D. M. Taylor, C. W. Mays, G. B. Gerber and R. G. Thomas, Eds.), pp. 108-111. BIR Report 21, British Institute of Radiology, London, 1989.
46. P. P. Kesava, J. Perl, M. P. Metha, T. B. Warner, V. B. Graves and C. M. Strother, Thorotrast-associated oropharyngeal hemorrhage: treatment by means of carotid occlusion with use of flow arrest and fibered coils. J. Vasc. Interv. Radiol. 7, 709-712 (1996).
47. L. G. Littlefield, L. B. Travis, A. M. Sayer, G. L. Voelz, R. H. Jensen and J. D. Boice, Jr., Cumulative genetic damage in hematopoietic stem cells in a patient with a 40-year exposure to alpha particles emitted by thorium dioxide. Radiat. Res. 148, 135-144 (1997).
48. S. H. Zahm and J. F. Fraumeni, Jr., The epidemiology of soft tissue sarcoma. Semin. Oncol. 24, 504-514 (1997).